Clobetasol Foam for Psoriasis

Title: Clobetasol propionate foam in the treatment of psoriasis.
: Reid DC and Kimball AB
Publication: Expert Opin Pharmacother. 2005 Aug;6(10):1735-40.

Psoriasis is a common, chronic skin disorder that commonly affects the scalp, skin, nails, and joints. Despite treatment, many patients still suffer from psoriasis, particularly the hard-to-treat form of scalp-type psoriasis.

The mainstay therapy for moderate-to-severe scalp psoriasis is topical corticosteroid. However, patients frequently object to the messiness and poor cosmetic appearance of this form of treatment.

The authors suggested foam-based clobetasol propionate 0.05% as a treatment, since it has minimal residue and better ease of application, as compared to traditional forms such as creams, ointments, and solutions.

Clobetasol propionate 0.05% has been shown to alleviate the symptoms of several skin diseases, including scalp and body psoriasis, improved the severity of these diseases, and increase the patient’s quality of life.

The dose of this medication should be limited to 50 gram per week, because of the risk of adrenal gland suppression.

Main Menu
Health Articles
Health News
Health Research
Site Map

Health Conditions
Cardiovascular Health
Digestive Health
Infectous Diseases
Musculoskeletal Health
Pregnancy & Childbirth
Skin Health

Misc. Health Articles
Presidential Diseases

Medical Research

Psoriasis Overview
Psoriasis Pictures
Research Summaries

©copyright 2004 - Health In Plain English. All Rights Reserved.

Health Articles Health News Health Research Explained in Plain English